Načítá se...
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
SIMPLE SUMMARY: Acquired resistance to molecularly targeted therapies remains a major challenge in the treatment of cancer. It has been hypothesized that drug-tolerant (or “persister”) cells without bona fide resistance mechanisms may survive initial drug treatment and undergo further evolution over...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8198243/ https://ncbi.nlm.nih.gov/pubmed/34071428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112666 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|